Mohammad AskarPublic working copy · medical review pending

Retina · 016

Read retinal OCT systematically

Check image quality, locate the abnormality, then connect it with symptoms, examination and change over time.

Working copy published: 2026-11-06T03:47:16+01:00. Source, translation and medical checks remain open. Limitations are stated in the text and references. Editorial text version: 2026-11-05 00:21 CET.

Describe what the scan shows before naming a disease. A thickness map or a single bright or dark feature cannot establish the diagnosis or determine treatment alone.

Terminology and draft status

Original terms and source questions are retained. Arabic medical translations are working copies; further compound-term WHO UMD checks remain pending. Source, translation and medical approval remain pending.

01Start with a scan you can interpret

Confirm the patient, eye, date and scan protocol. Check signal quality, fixation, centration and the segmentation lines before reading a thickness map. 15

Move through the whole volume and compare adjacent B-scans. A single selected image may miss a lesion; apparent change should be checked against earlier scans from the same location. 15

OCT shows optical reflectivity rather than a tissue biopsy. The term optical biopsy is a useful analogy, but every bright band cannot be assigned unambiguously to one histological structure. 1 2

Record contour, layer integrity and material as well as thickness. Qualitative and quantitative findings complement each other; neither replaces symptoms, fundus examination and the clinical course. 1 15

In highly myopic eyes, inspect the actual retinal curvature and scan window. A posterior staphyloma, tilted scan, truncation, mirror artefact or segmentation error may distort the display; repeat or reposition a doubtful scan before calling the change swelling. 15

A flattened display changes how curvature is presented. Check the original B-scans and device settings; the tilted appearance alone does not prove disease or establish which processing step caused it. 15

02Locate the layer and its blood supply

Read from the vitreoretinal interface through the inner and outer retina to the retinal pigment epithelium (RPE), Bruch membrane and choroid. The table retains ten teaching landmarks; OCT bands and the conventional ten histological retinal layers are not identical lists. 1 2

The external limiting membrane (ELM) corresponds to junctional complexes involving Müller cells and photoreceptors. The ELM junctions provide structural support and limit passage of larger molecules; this is not a literal continuous membrane. The ellipsoid zone (EZ) is a consensus optical landmark in the photoreceptor inner-segment region, rather than a direct count of mitochondria or surviving cells. 1 2 18

Henle fibres contain obliquely running photoreceptor axons and Müller-cell processes. Their visibility depends on beam direction, so the apparent boundary of the outer nuclear layer (ONL) can vary with acquisition. 1 16

Inner retinal perfusion is supplied by the retinal circulation; the outer retina depends predominantly on the choroidal circulation. The parafovea has superficial, intermediate and deep capillary networks, rather than a universally applicable two-plexus model. 3

A prospective cross-sectional OCT angiography study examined 20 eyes of 10 healthy people and identified connections to all three parafoveal plexuses. Small healthy samples and segmentation-dependent imaging describe anatomy; they do not establish disease-specific diagnostic accuracy. 3

Acute retinal arterial ischaemia can produce inner retinal thickening and hyperreflectivity. Apparently preserved outer bands do not exclude an arterial occlusion; sudden visual loss requires urgent clinical assessment. 3 15

The macula is conventionally described as approximately 5.5 mm across, centred on the fovea. The umbo is the central depression in the foveola; distinguish these anatomical regions from the foveal avascular zone (FAZ). 1

The FAZ describes the central absence of retinal capillaries, not an absence of choroidal supply. Abnormal vessels, including retinal angiomatous proliferation (RAP, also termed type 3 macular neovascularisation), require assessment of location, fluid, haemorrhage and function; the name alone does not predict a fixed degree of vision loss. 3 6

Locate the layer and its blood supply
LandmarkTypical appearanceMeaning and limitation
ILM — internal limiting membraneThin reflective interfaceVitreoretinal boundary; inspect for ERM and traction.
RNFL — retinal nerve fibre layerHyperreflectiveGanglion-cell axons; assess quality before glaucoma interpretation.
GCL — ganglion cell layerRelatively hyporeflectiveCell bodies; macular analysis complements RNFL without a fixed order of injury.
IPL — inner plexiform layerRelatively hyperreflectiveSynaptic region involving bipolar, amacrine and ganglion cells.
INL — inner nuclear layerRelatively hyporeflectiveBipolar, horizontal, amacrine and Müller-cell bodies.
OPL — outer plexiform layerRelatively hyperreflectivePhotoreceptor synaptic region; Henle fibres complicate the OCT boundary.
ONL — outer nuclear layerRelatively hyporeflectiveRod and cone nuclei; apparent thickness may include Henle fibres.
ELM — external limiting membraneThin hyperreflective bandMüller/photoreceptor junctional complexes; not simply Müller-cell ends; structural support and a barrier to larger molecules.
EZ — ellipsoid zoneHyperreflective zonePhotoreceptor inner-segment landmark; continuity is a disease-dependent marker.
RPE — retinal pigment epitheliumHyperreflective outer band/complexPhotoreceptor support and outer barrier; distinguish RPE, Bruch membrane and choroid.

03Understand the device before comparing measurements

Time-domain OCT samples reflected signals with a changing reference delay. Spectral-domain (SD) OCT detects a spectrum, while swept-source (SS) OCT uses a wavelength-swept light source; both Fourier-domain approaches derive depth information computationally. 5 15

Many retinal SS-OCT systems operate around 1050 nm, which can improve imaging of deeper choroidal structures. This is a device-specific range, not a guarantee of image quality, penetration or clinical superiority; enhanced-depth SD imaging can also be useful. 5

For example, the historical PLEX Elite 9000 software 1.0 submission describes 1060 nm and a technical comparison with 840 nm CIRRUS imaging. A historical regulatory technical assessment is not a current instruction for every ZEISS, Heidelberg or Alcon product. 5

Record the exact model, software and scan protocol. Manufacturers and versions may place outer thickness boundaries at different RPE or Bruch-membrane landmarks; their values and normative classifications are not automatically interchangeable. 4 15

A retrospective study of 184 eyes from 106 people found different retinal thickness values across two SD systems and time-domain imaging, with differences varying by diagnosis. Historical estimates cannot be used as a universal conversion formula for current devices. 4

For follow-up, use the same system where possible and inspect registered B-scans, not just a numerical trend. A software or device change may require a new baseline; acquisition speed does not remove motion, alignment or segmentation artefacts. 15

04Describe fluid, material and outer retinal integrity

Start with the interface and foveal contour, then describe each affected layer and the extent of abnormality. Inspect the same finding in neighbouring scans before assigning a mechanism. 1

Use greyscale images to judge reflectivity and fine structure. Pseudocolour is a display transformation; interpret it alongside greyscale and the original scan rather than treating a colour as a tissue diagnosis. 1 2

Intraretinal fluid (IRF) refers to fluid within the retina, often seen as cystoid hyporeflective spaces in diabetic macular oedema (DMO) or other macular oedema. A dark cavity can also reflect traction or degenerative remodelling; shape, borders and serial change matter. 16

Outer retinal tubulation (ORT), for example, may have an ONL location and a hyperreflective boundary. OCT–histology comparison in advanced AMD distinguished these degenerative structures from cysts; the presence of a cavity does not by itself justify an injection. 16

Subretinal fluid (SRF) lies between the neurosensory retina and RPE. Subretinal hyperreflective material (SHRM) is a descriptive finding that can include blood, exudative or neovascular material and fibrosis; use clinical and multimodal findings to interpret it. 6 16

Describe ELM, EZ and RPE continuity because outer retinal damage may help explain limited vision despite less fluid. Prognosis also depends on the disease, duration, foveal involvement and baseline function; an isolated EZ interruption is not a universal point of irreversible loss. 1 2 16

05Use the pattern to narrow the differential

In AMD, describe drusen beneath the RPE, a pigment epithelial detachment (PED), associated fluid and hyperreflective material. PED describes an elevation, not one cause; its contents and neighbouring abnormalities determine the differential. 6

Hypertransmission means that more OCT signal passes below the RPE region. To classify complete RPE and outer retinal atrophy (cRORA), the CAM consensus combines hypertransmission and RPE attenuation/disruption each at least 250 µm across, overlying photoreceptor degeneration and no signs of an RPE tear. 6

Hypertransmission alone does not establish complete atrophy or a visual prognosis. Confirm outer retinal and RPE changes across scans and use complementary imaging where findings remain uncertain. 6

Central serous chorioretinopathy (CSC; CCS/CSR in the original notes) often shows SRF with choroidal vascular changes, including enlarged Haller-layer vessels. Choroidal thickness alone is insufficient; look for alternative causes and secondary macular neovascularisation. 7 9

In acute CSC, observation for about 3–4 months is often reasonable, with review of corticosteroid exposure and other risks. The 2021 German statement is more restrictive about early treatment than the 2024 evidence-based guideline, which allows selected earlier PDT; this is not a fixed waiting rule for every patient. 7 9

Half-dose photodynamic therapy (PDT) reduces the verteporfin dose; half-fluence PDT reduces delivered light energy. They are different modifications. Chronic CSC assessment should distinguish PDT, micropulse protocols and focal laser options rather than present them as equally supported substitutes. 7 8 9

PLACE was an open-label multicentre randomised trial in 179 people with chronic CSC: 89 received half-dose PDT and 90 high-density subthreshold micropulse laser. Complete SRF resolution at 6–8 weeks was 51.2% versus 13.8%; at 7–8 months it was 67.2% versus 28.8%, both P < 0.001. 8

Early mean acuity gains in PLACE were 4.60 versus 1.39 ETDRS letters (P = 0.011); the difference in vision-related quality-of-life improvement was not statistically clear (P = 0.800), which does not establish equivalence. Anatomical success and functional benefit are distinct; interpret secondary outcomes cautiously given open-label allocation, particular treatment protocols and limited follow-up. 8

Stress support may help wellbeing, but stress reduction is not a proven substitute for disease-directed CSC management. The German statement notes the lack of high-quality intervention evidence; review steroid changes with the prescriber and investigate suspected neovascularisation. 9

With hydroxychloroquine (HCQ), look for early parafoveal or pericentral outer retinal thinning and EZ changes before a visible bull’s-eye maculopathy. A bull’s-eye appearance is a late manifestation, not a necessary screening finding. 10 11

The AAO 2025 revision, published in 2026, uses OCT with wide-pattern fundus autofluorescence (FAF) as primary screening tools; visual fields and multifocal electroretinography (mfERG) provide confirmation. The German S1 guideline starts with OCT and asks for a second objective test when findings are suspicious; neither establishes that FAF invariably detects toxicity first. 10 11

Assess both parafoveal and pericentral regions. A 10-2 field samples central points densely; wider 24-2 or 30-2 testing, or an appropriately combined 24-2C strategy, may be needed. Ancestry can guide attention but does not determine the pattern or mandate one grid for every Asian or Indian patient. 10 11

Check the screening baseline, exposure and risk factors, and discuss reproducible suspicious findings with the prescribing clinician. Do not advise a patient to stop HCQ solely because of one uncertain OCT, FAF or field result. 10 11

For vitreomacular traction (VMT), macular hole or epiretinal membrane (ERM), describe attachment, foveal deformation and any partial- or full-thickness defect. The cotton-ball sign is a central hyperreflective feature between outer retinal bands; it is distinct from a hyporeflective pseudocyst. 12 13

The original retrospective cotton-ball series included 54 eyes of 45 symptomatic people: the sign occurred in 7 of 7 VMT eyes and 30 of 47 ERM eyes and disappeared after traction release. This selected descriptive series did not validate a risk percentage or reliable prediction of an impending macular hole. 12

A later retrospective ERM series found central-bouquet abnormalities in 58 of 263 eyes (22%); sequential morphological change was seen in 7 eyes. It described a spectrum including cotton-ball sign, foveolar detachment and acquired vitelliform lesions, not a universal progression sequence or hole-prediction rule. 13

For ERM, assess metamorphopsia, acuity, daily function, fellow-eye status and the likely benefits and risks of surgery. The AAO summary notes that many membranes remain stable; an abnormal OCT alone is not an automatic indication for peeling. 17

06Combine macular and peripapillary glaucoma information

The retinal nerve fibre layer (RNFL) contains ganglion-cell axons; macular analysis evaluates cell bodies and, depending on the software, the inner plexiform layer or a broader ganglion-cell complex. GCL, GC-IPL and GCC are related but not interchangeable measurements. 14 15

Combine disc examination, peripapillary RNFL, macular findings and visual fields. Macular damage may add useful information, including in normal-tension glaucoma, but no universal order requires GCL loss to precede RNFL or functional loss in each eye. 15

In advanced disease, a measurement floor limits the detection of further thinning. Bowd and colleagues used 41 eyes to estimate variability and 87 advanced-glaucoma eyes to study change; more macular GC-IPL area remained above the floor than circumpapillary RNFL area. 14

This supports a possible residual role for macular analysis, not a universal threshold or proof of clinical superiority at every stage. Advanced-stage OCT remains limited by measurement floors; prioritise functional testing and clinical correlation rather than rely on OCT alone. 14 15

An apparently missing RNFL signal can reflect poor acquisition, shadowing or segmentation as well as severe disease. Inspect and repeat the scan; complete signal dropout is not by itself proof of irreversible ganglion-cell loss. 15

07Turn the description into a clinical next step

Use the comparison table as a differential, not a list of diagnostic shortcuts. State the finding, its location, plausible causes and what would confirm or challenge your interpretation. 1 6 12 15

For an examination presentation, identify the image-quality limits, describe the layers, give a focused differential and propose the next examination or comparison. Avoid confusing ILM with RPE or overlooking the choroid when CSC is suspected. 1 7

When imaging and symptoms disagree, review the scan and examination rather than force a diagnosis from the map. Repeat acquisition or add appropriate multimodal imaging when it will resolve a specific uncertainty. 15

Turn the description into a clinical next step
FindingPossible explanationNext check
ShadowingPigment, blood, hard exudates or acquisition-related attenuationInspect material at or above the shadow; do not assume that obscured tissue is absent.
HypertransmissionReduced attenuation near the RPE, including atrophyAssess RPE and photoreceptor changes together; isolated signal transmission is not complete atrophy.
Cotton-ball signTraction-related central hyperreflective materialAssess ERM/VMT, foveal structure and symptoms; no validated impending-hole risk follows from the sign alone.
Inner retinal hyperreflectivityPossible acute arterial ischaemiaCorrelate immediately with symptoms and examination; an OCT pattern alone cannot establish the cause.
Which checks come first when reading an OCT?

Confirm patient and eye, scan protocol, signal quality, fixation, centration and segmentation boundaries, then inspect the B-scans.

Why should a thickness map never be interpreted alone?

Segmentation errors and local artefacts can create misleading values. Check the underlying B-scans, acquisition and clinical context before interpreting apparent change.

References and access status

  1. 1
    IN•OCT consensus — Staurenghi et al., 2014

    Complete indexed abstract read; consensus terminology, not a validated one-to-one histological map. Full report/figures pending.

  2. 2
    Anatomical correlates of outer retinal bands — Spaide and Curcio, 2011

    Complete indexed abstract and selected primary manuscript passages read; anatomical model, not direct proof of every optical source. Full report/figures pending.

  3. 3
    Parafoveal capillary anatomy — Nesper and Fawzi, 2018

    Complete indexed abstract and selected main-paper anatomy/discussion passages read; small healthy cross-sectional study. Full report and image appraisal pending.

  4. 4
    Retinal thickness across OCT systems — Han and Jaffe, 2009

    Complete indexed abstract read; retrospective historical device comparison. Full report and current product instructions pending.

  5. 5
    FDA K161194 — PLEX Elite 9000, software 1.0, 2016

    Selected regulator letter, device/technical and bench sections read; historical submission, not current local instructions or a general superiority trial.

  6. 6
    CAM Report 3 — Sadda et al., 2018

    Complete indexed abstract and selected primary criteria passages read. Corrigendum PMID30577915 identified but its body remains unread; detailed finalisation pending.

  7. 7
    CSC evidence-based treatment guideline — Feenstra et al., 2024

    Complete indexed abstract read; evidence-based clinical synthesis. Full methods, references and underlying reports pending.

  8. 8
    PLACE — van Dijk et al., 2018

    Complete indexed primary abstract read; open-label chronic-CSC randomised comparison. Full report, protocol, masking and missing-data assessment pending.

  9. 9
    DOG/BVA/RG CSC statement, October 2021

    Officially linked statement: selected summary, acute-treatment/risk and micropulse passages read. Full document and cited trials not completely appraised; distinguish historical recommendations from later evidence.

  10. 10
    AAO HCQ screening — Marmor et al., 2025 revision / 2026 publication

    Complete indexed abstract and selected indexed clinical-test passages read. Direct official page/PDF retrieval failed; no full-report or figure review claimed.

  11. 11
    DOG/BVA/RG S1 HCQ screening, version 1, July 2025 — AWMF045-016

    Selected official extracted recommendations and clinical text through management/figure captions read. Images, full methods, references and conflicts not fully appraised; terminology/numeric inconsistencies recorded separately.

  12. 12
    Cotton-ball sign — Tsunoda et al., 2012

    Complete indexed primary abstract and first-page manuscript passages read; selected symptomatic retrospective series. Full report and linked comment bodies pending.

  13. 13
    Central foveal bouquet in ERM — Govetto et al., 2018

    Complete indexed primary abstract read; retrospective observational spectrum, not validated hole prediction. Full report pending.

  14. 14
    Glaucoma OCT measurement floors — Bowd et al., 2017

    Complete indexed primary abstract read; device/sample-dependent validity study. Full report/protocol appraisal pending.

  15. 15
    European Glaucoma Society Guidelines, sixth edition, 2025

    Selected OCT diagnostic/progression text and TableII.1, printed pages100–102, read. Advanced-stage wording tension retained; no new full-book review claimed.

  16. 16
    Outer retinal tubulation and histology — Schaal et al., 2015

    Complete indexed abstract and selected primary methods/figure-caption passages read. Clinical and donor series provide morphological correlation; full report and actual figure-image review pending.

  17. 17
    AAO Retina Summary Benchmarks, December 2025 — ERM/VMT

    Selected official indexed ERM/VMT recommendations, printed page7, read. The full ERM/VMT PPP has been identified but not fully read; no complete guideline appraisal claimed.

  18. 18
    Cellular origins of outer retinal OCT bands — Jonnal et al., 2014

    Complete indexed primary abstract and selected ELM/outer-band discussion read; small adaptive-optics study, not full article/figures or the underlying molecular-barrier experiment. Exact band origin remains debated.

Original lecture links